PRO 140, an innovative new therapy for HIV patients developed by Cytodyn Inc. (OTCQB: CYDY), is currently undergoing phase 3 clinical trials, having been administered to several patients, according to a company press release (http://dtn.fm/F40vr). No other details were provided about the initial results of phase 3 trials, but a separate report said actor Charlie […]

Moxian, Inc. (NASDAQ: MOXC), a top digital marketing company, uses powerful social media-driven marketing and sales tools to connect online users and merchants. Backed by a flourishing online-to-offline integrated platform, this company offers offline merchants solid opportunities to strengthen their outreach to digital consumers. Since it was founded in 2013, Moxian has catered to one […]

According to 4Hoteliers (http://dtn.fm/zOeA9), 85% of travelers across the world are also smartphone users. The article goes on to state that 32% of these travelers use their mobile devices to book travel-related services. The company’s recent webinar, ‘Digital Marketing and Mobile Trends Impacting the Travel Industry’, showed that over 70% of travelers use mobile devices […]

MediWound Ltd. (NASDAQ: MDWD) is a biopharmaceutical company in the business of developing, manufacturing, and globally commercializing products that treat severe burns and wounds. In 2012, MediWound’s innovative drug, NexoBrid™, a burn and wound eschar removal agent, was approved by the European Medicines Agency (EMA) via a centralized procedure. The drug was given orphan indication […]

As an eventful year for Globus Medical, Inc. (NYSE: GMED) is nearing an end, the leading medical device company experienced a substantial surge in trading volume on December 06. Equities.com (http://dtn.fm/Rab1C) noted a 1.3% gain of Globus Medical, Inc. Class A stock, closing at $23.31. The stock, which averages a daily volume of 1.11 million […]

Intellipharmaceutics International, Inc. (NASDAQ: IPCI) is a pharmaceutical company in the business of researching, developing, and manufacturing new and generic controlled and targeted release oral solid dosage drugs. The company has a large product portfolio which all follow a New Drug Application (NDA) 505(b)(2) U.S. Food and Drug Administration (FDA) regulatory pathway. The company’s controlled-release […]

Revance Therapeutics, Inc. (NASDAQ: RVNC), a biotechnology company focused on the development, commercialization, and manufacture of botulinum toxin products for use in aesthetic and therapeutic indications, including dermatology and neurology, recently announced its operating results for the third quarter of 2016 ended September 30. A summary of the company’s financial results highlighted research and development […]

Now that residents of the Golden State have approved Proposition 64, California joins the District of Columbia and the states of Alaska, Colorado, Maine, Massachusetts, Nevada, Oregon, and Washington in legalizing the recreational use of marijuana for adults. Together, these eight states and the U.S. capital generate about one-quarter of U.S. gross domestic product (GDP). […]

The Trade Desk, Inc. (NASDAQ: TTD) is a technology company that allows buyers to use proprietary data to better target their advertising dollars. With The Trade Desk platform, organizations are able to use fully automated and programmatic means to buy advertising space on a range of media where specific consumers are more likely to use […]

On December 1, 2016, OurPet’s Company (OTCQX: OPCO) gave an investor presentation with VirtualInvestorConferences.com (powered by PR Newswire), in which its management team laid out the reasons they feel the company is significantly undervalued, with established and continuing growth in its market and company figures, along with products and technology that nobody else has, making […]